Yoshitomi Munehiro, Horiuchi Hiroyuki, Kawahara Ryuichi, Uchida Shinji, Hisaka Tohru, Sakai Takenori, Maruyama Yuichiro, Kinoshita Hisafumi
Dept. of Surgery, Kurume University School of Medicine.
Gan To Kagaku Ryoho. 2008 Nov;35(12):2129-31.
The patient was a 73-year-old man. In 2001, PPPD was performed. After confirmation of an expanded intrahepatic bile duct and anastomic stenosis in July 2005, PTBD was performed into the B3. Adenocarcinoma was detected with bile cytodiagnosis, and was diagnosed as a recurrence of the left bile-duct anastomotic site. Under the informed consent, chemo-radiotherapy was performed in addition to beam radiotherapy (30 Gy) in September 2005. Then we performed an intracavitary irradiation at 25 Gy. UFT (200 mg) was administered along with the radiation therapies. After that, an internal fistularization due to the T-tube was done. Liver metastasis was confirmed by abdominal CT in 2006. We started administering of GEM (600 mg/body) every other week after the recurrence of the bile duct cancer. The patient had survived for 24 months from the recurrence. We report a good result of the recurrent bile duct cancer treated with combined modality therapy.
